Himeno Takahiro, Ota Shinzo, Ohtonari Tatsuya, Kanbara Mizuki, Takemaru Makoto, Nomura Eiichi, Kohriyama Tatsuo
Department of Neurology, Brain Attack Center Ota Memorial Hospital, Fukuyama, Hiroshima, Japan.
Department of Neurosurgery, Brain Attack Center Ota Memorial Hospital, Fukuyama, Hiroshima, Japan.
J Neuroendovasc Ther. 2020;14(1):36-42. doi: 10.5797/jnet.tn.2019-0054. Epub 2019 Dec 6.
We aimed to investigate the efficacy of the insertion-support guiding catheter (ISGC) for approaching target lesions during endovascular therapy in patients with severe atherosclerotic or tortuous arteries.
The ISGC is an 8 Fr, JB2 shape, stiff-type, short guiding catheter. We used ISGC for 52 patients between April 2007 and March 2018, microcatheters or therapeutic devices were delivered to target lesions via ISGC in 46 (88.4%) of the 52 patients, and none of them developed associated complications. Herein, we present three representative cases.
An ISGC is useful for vascular intervention in patients with atherosclerotic or tortuous arteries.
我们旨在研究插入支撑引导导管(ISGC)在严重动脉粥样硬化或迂曲动脉患者血管内治疗过程中接近靶病变的疗效。
ISGC是一种8F、JB2形状、硬型、短引导导管。2007年4月至2018年3月期间,我们对52例患者使用了ISGC,52例患者中有46例(88.4%)通过ISGC将微导管或治疗装置送达靶病变,且无一例发生相关并发症。在此,我们展示三个典型病例。
ISGC对动脉粥样硬化或迂曲动脉患者的血管介入治疗有用。